Immunohistologic evaluation effect cyclosporine treatment lichen planus immune infiltrate cutaneous immune infiltrate lesions patients severe extensive lichen planus recent onset days oral low-dose cyclosporine therapy mg/kg/day therapy abnormal bandlike cellular infiltrate papillary dermis cells prevalence cells lymphocytes markers activation HLA-DR antigens interleukin receptor many Langerhans cells dermal infiltrate days cyclosporine therapy dramatic decrease total number cells corresponding decrease interleukin receptor-positive cells antigen-presenting cells changes concurrent clinical improvement results compatible hypothesis inhibition cells cyclosporine drug therapeutic action interaction antigen-presenting cells cells important pathogenesis lichen planus 